Coherent Biopharma
Established in 2016, Coherent Biopharma’s proprietary bi-targeting XDC technology platform includes BESTTM Platform, C-PROTAC Platform and Chronic Diseases Platform. With the possibility to actively and cell/tissue specifically deliver any bioactive molecule, bi-targeting XDC technology of CBP has the potential to overcome the undruggability obstacle of a variety of molecules with high bioactivity, thus to Drug the Undruggable, and pioneer a new pathway of drug development.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
6
51 to 200 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Coherent Biopharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Coherent Biopharma
5 distinct titles indexed · top 5 shown.
- 1executive director,clinical qa
- 1hrd
- 1investment director
- 1president of r & d
- 1人力资源
Sign up to unlock all 5 contacts at Coherent Biopharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Coherent Biopharma
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.